Question follow-through · 32000
CJD: Medical Treatments
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help support advances n CJD treatment.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 21 Feb 2025
- Target answer date
- 25 Feb 2025
- Answer
- 3 Mar 2025 · 10 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Spinal Muscular Atrophy: Screening · 17 Apr 2025
- Spinal Muscular Atrophy: Screening · 17 Apr 2025
- Spinal Muscular Atrophy: Screening · 17 Apr 2025
- Spinal Muscular Atrophy: Screening · 17 Apr 2025
- Diseases · 13 May 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
21 Feb 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help support advances n CJD treatment.
25 Feb 2025
Target answer date
Date supplied by the official written-questions record.
3 Mar 2025
Answer published
Creutzfeldt-Jakob disease (CJD) is a rapidly progressing neurodegenerative disease. As of yet, there is no cure. Treatment options focus on symptom control and palliative care.The Department, via the National Institute for Health and Care Research, funds ...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Spinal Muscular Atrophy: Screening
17 Apr 2025 · To ask the Secretary of State for Health and Social Care, what his timetable is for releasing funds to support the UK National Screening Committee’s review of newborn screening for Spinal Muscular Atrophy.
Spinal Muscular Atrophy: Screening
17 Apr 2025 · To ask the Secretary of State for Health and Social Care, what the planned timetable is for the UK National Screening Committee's review of its advice on screening for spinal muscular atrophy.
Spinal Muscular Atrophy: Screening
17 Apr 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of concerns raised by the Spinal Muscular Atrophy (SMA) stakeholder community on the speed of progress being made by the UK National Screening Committee in its work to s
Spinal Muscular Atrophy: Screening
17 Apr 2025 · To ask the Secretary of State for Health and Social Care, what discussions he has had with the National Institute for Health and Care Research on expediting the publication of its research brief to inform the UK National Screening Committee’s in-service e
Diseases
13 May 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the (a) National Disease Registration Service and (b) National Congenital Anomaly and Rare Diseases Registration Service continue after the planne
Rare Diseases: Health Services
30 May 2025 · To ask the Secretary of State for Health and Social Care, how the NHS 10 year plan will improve the delivery of healthcare for people with rare conditions.
Rare Diseases: Health Services
30 May 2025 · To ask the Secretary of State for Health and Social Care, whether the specific challenges of providing specialised care for rare conditions will be included in the NHS 10 year plan.
Rare Diseases
30 May 2025 · To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of the abolition of NHS England on people with rare conditions.
Rare Diseases: Drugs
30 May 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential impact of suspending the medicines repurposing programme on people affected by rare conditions.
Cannabis: Medical Treatments
18 Nov 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to bring responsibility for medical cannabis policy and governance to his Department in line with Schedule 2 medicines.
Cannabis: Medical Treatments
18 Nov 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support and fund clinical trials aimed at achieving licensing and NHS access for complex, cannabis-based medicines used in the treatment of severe, drug-resis
Multiple Sclerosis: Health Services
9 Dec 2025 · To ask the Secretary of State for Health and Social Care, what data his department collects to monitor potential inequalities in multiple sclerosis care access; and how those findings are used to inform policy and service delivery improvements.